Acelyrin Stock (NASDAQ: SLRN) stock price, news, charts, stock research, profile.
Open | $6.91 |
Close | - |
Volume / Avg. | 140.11K / 951.10K |
Day Range | 6.63 - 6.96 |
52 Wk Range | 3.67 - 29.88 |
Market Cap | $662.49M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 68 |
Short Interest | 8.18% |
Days to Cover | 6.39 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Acelyrin (NASDAQ:SLRN) through any online brokerage.
Other companies in Acelyrin’s space includes: KalVista Pharma (NASDAQ:KALV), Celcuity (NASDAQ:CELC), Replimune Group (NASDAQ:REPL), Sage Therapeutics (NASDAQ:SAGE) and Fate Therapeutics (NASDAQ:FATE).
There is no analysis for Acelyrin.
Acelyrin has a consensus price target of $22.00.
The stock price for Acelyrin (NASDAQ: SLRN) is $6.69 last updated Today at July 24, 2024 at 12:49 PM EDT.
There are no upcoming dividends for Acelyrin.
Acelyrin’s Q2 earnings are confirmed for Monday, August 12, 2024.
There is no upcoming split for Acelyrin.
Acelyrin is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.